- Second Chapter 11 filing tied to settlement seen as ‘gamble’
- J&J offering $8.9 billion to resolve all talc-cancer lawsuits
But on Tuesday, just hours after a judge officially ended that first effort, J&J tried the gambit again. The company put the same subsidiary that had been tossed out of bankruptcy court back into Chapter 11, this time with a plan to pay $8.9 billion to resolve the decades-old cancer claims. The move has already drawn the ire of some victim lawyers and raised eyebrows among legal scholars, who are asking why this time will be any different.
“They are taking a massive gamble here,” said
J&J faces two major hurdles: it must survive any new legal challenge from opponents who are likely to argue the second case is just as flawed as the first, and it has to convince 75% of all victims to vote in favor of the deal.
About two months ago, an appeals court
In the new case, J&J argues this one is different because they have support from many more cancer victims. That shows the company is acting in good faith, and the new case also meets a test set by the appeals court in Philadelphia, lawyers for the bankrupt subsidiary said in court documents filed Tuesday.
The effort may be worth it for J&J, which has struggled for years to manage claims that asbestos-tainted talc in its baby powder caused ovarian cancer and mesothelioma. In 2021, prior to LTL’s first Chapter 11 filing, the company unsuccessfully offered
‘Significant Progress’
“The re-filing represents significant progress toward a plan for efficient and effective resolution that addresses the concerns raised by the Third Circuit, is consistent with the bankruptcy code and currently supported by roughly 70,000 claimants and numerous plaintiff law firms,”
J&J has steadfastly maintained its baby powder — sold in distinctive white bottles — never contained asbestos, is safe and doesn’t cause cancer. Company officials said they sought to settle suits to avoid hundreds of millions in legal fees and a wave of trials.
But since 2013, juries ruled against the company in nearly a dozen cancer suits — including one appealed all the way to the US Supreme Court — before J&J was forced to pay
In 2020, J&J pulled its talc-based baby powder off the US market and replaced it with a cornstarch-based product. It’s also planning to take the talc-based powders off the market
J&J first put LTL into bankruptcy in 2021 and within months convinced US Bankruptcy Judge
Victims challenged Kaplan’s ruling and in January, a federal appeals court ordered Kaplan to
This time, LTL and J&J have a deal to pay only $8.9 billion and only as part of a bankruptcy case, according to court documents. That means LTL is “sufficiently distressed” to withstand appellate scrutiny, according to Tuesday’s filing.
“The ultimate question is, does this meet the test the appeals court applied in the first case?” said Anthony Casey, a law professor at the
Some legal experts doubt the US Third Circuit Court of Appeals – which tossed the first case – will buy what they ridicule as cosmetic changes to LTL’s new Chapter 11 filing.
‘Audacious Ploy’
“This is a rather audacious ploy,” said Ralph Brubaker, a law professor at the University of Illinois. “Such cynical strategic machinations to manufacture self-inflicted financial distress hardly bolster the case for a legitimate, good faith resort to bankruptcy relief.”
Others point to a footnote in the appeals court’s January decision that appeared to anticipate LTL’s second trip through bankruptcy. US Circuit Judge
“Some might read our logic to suggest LTL need only part with its funding backstop to render itself fit for a renewed filing,” Ambro wrote. But that strategy would likely expose LTL to yet another type of legal challenge, he
The new bankruptcy filing is LTL Management LLC,
To contact the reporters on this story:
To contact the editors responsible for this story:
Jeremy Hill, Claire Boston
© 2023 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.